Author details

Full Name

Ze Tian

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36184366	'Corrigendum to "Aminoguanidine alleviated MMA-induced impairment of cognitive ability in rats by downregulating oxidative stress and inflammatory reaction" [Neurotoxicology 59 (2017) 121-130]'.	NeuroToxicology	2022
33508120	CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2.	Endocrinology	2021
28223158	Aminoguanidine alleviated MMA-induced impairment of cognitive ability in rats by downregulating oxidative stress and inflammatory reaction.	NeuroToxicology	2017
27118403	A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells.	Leukemia	2016
24612609	TIM4 Regulates the Anti-Islet Th2 Alloimmune Response.	Cell Transplant	2015
25940539	Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.	Oncotarget	2015
24319254	A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.	Blood	2014
24486586	Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease.	Clin Cancer Res	2014
24476765	A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.	Leukemia	2014
24185503	A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice.	Blood Cancer J	2013
22983447	Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.	Blood	2012
22975377	A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.	Cancer Cell	2012
21712951	Cambogin is preferentially cytotoxic to cells expressing PDGFR.	PLoS One	2011
21131428	Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1.	J Immunol	2011
21102427	HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.	Leukemia	2011
21724551	In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.	Clin Cancer Res	2011
21085674	Pre-clinical drug prioritization via prognosis-guided genetic interaction networks.	PLoS ONE	2010
18836721	Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.	Cancer Chemother Pharmacol	2009
19381341	A practical platform for blood biomarker study by using global gene expression profiling of peripheral whole blood.	PLoS One	2009
19809919	Chemical constituents from the fruits of Hippophae rhamnoides.	Natural Product Research	2009
18689692	Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.	Diabetes	2008
19030102	Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells.	PLoS One	2008
17847033	Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.	Int J Cancer	2008
17916414	Diarylheptanoids from the rhizomes of Alpinia officinarum and their anticancer activity.	Fitoterapia	2008
18166137	Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma.	BMC Cancer	2007
17518044	Diterpenes from Helianthus annuus and their cytotoxicity in vitro.	Yaoxue Xuebao	2007
17496413	Cytotoxic activity of schisandrolic and isoschisandrolic acids involves induction of apoptosis.	Chemotherapy	2007
17881166	Cimicifuga foetida extract inhibits proliferation of hepatocellular cells via induction of cell cycle arrest and apoptosis.	J Ethnopharmacol	2007
17718199	The constituents from the stems of Garcinia cowa Roxb. and their cytotoxic activities.	Die Pharmazie	2007
16521214	Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana.	World Journal of Gastroenterology	2006
17260803	[Cytotoxicity and mechanism of 23-O-acetylcimigenol-3-O-beta-D-xylopyranoside on HepG2 cells].	Zhongguo Zhong Yao Za Zhi	2006
17971743	Cytotoxicity of two triterpenoids from Nigella glandulifera.	Molecules	2006
16702811	Anti-cancer activity and mechanisms of 25-anhydrocimigenol-3-O-beta-D-xylopyranoside isolated from Souliea vaginata on hepatomas.	Anticancer Drugs	2006
16300906	Cytotoxicity of cycloartane triterpenoids from aerial part of Cimicifuga foetida.	Fitoterapia	2006
16830816	[Review of bioactivities of natural cycloartane triterpenoids].	Zhongguo Zhongyao Zazhi	2006
16428026	The cytotoxicity of naturally occurring styryl lactones.	Phytomedicine	2006
16004933	Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica.	Cancer Letters	2005
11668746	[Effect of two extracted fraction from Lycopus lucidus on coagulation function].	Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials	2001

1 - 38 of 38

Erxi Wu

Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin

Co-authored papers 14

Kenneth C Anderson

Dana Farber Cancer Institute

Co-authored papers 8

Isaac S Kohane

Harvard Medical School

Co-authored papers 5

Bin Zhou

The Central Hospital of Shaoyang

Co-authored papers 3

Bonnie Berger

Massachusetts Institute of Technology

Co-authored papers 2

Michal Galdzicki

University of Washington

Co-authored papers 2

Nathan Palmer

Harvard Medical School

Co-authored papers 2

Kenneth Law

Co-authored papers 2

Zhuyin Li

National Center for Advancing Translational Sciences, National Institutes of Health

Co-authored papers 1

Jeffrey A Kiefer

Co-authored papers 1

Joaquin Mateo

Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus

Co-authored papers 1

Yaqin Zhang

Jiangsu University Zhenjiang 212013

Co-authored papers 1

Robert C Smallridge

Mayo Clinic School of Medicine, Mayo Clinic

Co-authored papers 1

Jing Wang

Co-authored papers 1

John A Copland

Mayo Clinic Jacksonville

Co-authored papers 1

Matthew B Boxer

Co-authored papers 1

Amit Mehta

Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth

Co-authored papers 1

Zhiya Yu

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 1

Myriem Boufraqech

The University of Texas at Austin

Co-authored papers 1

Robert L Coffman

Co-authored papers 1

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 1

Susan R Davis

Co-authored papers 1

Min Shen

National Center for Advancing Translational Sciences, National Institutes of Health

Co-authored papers 1

Mikael Altun

Karolinska Institutet

Co-authored papers 1

Electron Kebebew

Stanford University School of Medicine

Co-authored papers 1